Company: SLNH
Filing Date: 2025-10-14
Form Type: DEF 14A
Source: 0001493152-25-018023
Chunk: 12

Company: Soluna Holdings, Inc
Filing Date: 2025-10-14
Form: DEF 14A
Chunk 12
---
UNDER FROM 75,000,000 SHARES TO 375,000,000 SHARES</div>

As of the date of this proxy statement, we were authorized under our Articles to issue up to a total of 85,000,000 shares of capital stock, comprised of 75,000,000 shares of common stock and 10,000,000 shares of preferred stock, par value $0.001 per share. Our Board believes that it is in the best interests of the Company and our stockholders to amend the Articles to increase the number of authorized shares of common stock. Upon consultation with our management, our Board unanimously approved, and unanimously recommends for stockholder approval, the proposal to approve an amendment to the Articles (the “Amendment”), to increase the number of shares of common stock authorized for issuance thereunder from 75,000,000 shares to 375,000,000 shares, each share of common stock having a par value of $0.001. The Amendment does not affect the number of shares of preferred stock authorized for issuance under the Articles.

The form of the text of the Amendment (which would be filed with the Nevada Secretary of State on its then-prescribed form of Certificate of Amendment) is set forth as Appendix Ato this proxy statement (subject to any changes required by applicable law).

As of the Record Date, there were 64,102,101 shares of our common stock outstanding and:

| ● | 2,645                                                                                      
 shares of our common stock issuable upon the exercise of options outstanding at a weighted 
 average exercise price of $21.45 per share;                                                |
| ● | 199,190                                                                                    
 shares of our common stock underlying restricted stock units;                              |
| ● | 1,250,000                                                                                  
 shares of our common stock issuable upon conversion of our Series B Convertible Preferred  
 Stock, par value $0.001 per share; and                                                     |
| ● | 7,722,890                                                                                  
 shares of our common stock issuable upon the exercise of outstanding warrants, including   
 pre-funded warrants, at a weighted average exercise price of $2.06 per share.              |

The additional shares of common stock to be authorized by approval of the Amendment would have rights identical to the currently outstanding shares of common stock. Approval of the Amendment would not affect the rights of the holders of currently outstanding common stock, except, to the extent the additional authorized shares are issued, for effects incidental to increasing the number of shares of common stock outstanding, such as dil